Paget's disease of the breast differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 26: Line 26:
! rowspan="5" |Benign or Malignant
! rowspan="5" |Benign or Malignant
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! colspan="8" |Clinical manifestations
! colspan="9" |Clinical manifestations
! colspan="2" rowspan="2" |Para-clinical findings
! colspan="2" rowspan="2" |Para-clinical findings
| rowspan="5" |Gold Standard
| rowspan="5" |Gold Standard
Line 32: Line 32:
|-
|-
! colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! colspan="2" rowspan="2" |Physical examination
! colspan="3" rowspan="2" |Physical examination
|-
|-
!Lab Findings
!Lab Findings
Line 40: Line 40:
! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Itching
! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Itching
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mastalgia
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mastalgia
! rowspan="2" |Breast Exam
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum IgE  
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum IgE  
Line 69: Line 70:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | –
| align="center" style="background:#F5F5F5;" | –
|
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Centrofacial pallor
* Centrofacial pallor
Line 108: Line 110:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
|
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Stinging and burning
* Stinging and burning
Line 133: Line 136:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
|
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Swelling]], [[Blister|blistering]] and scaling of the damaged area
* [[Swelling]], [[Blister|blistering]] and scaling of the damaged area
Line 163: Line 167:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
|
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Auspitz's sign]]  (pinpoint bleeding)
* [[Auspitz's sign]]  (pinpoint bleeding)
Line 191: Line 196:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
**  
**  
|
| align="center" style="background:#F5F5F5;" | Nl
| align="center" style="background:#F5F5F5;" | Nl
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 196: Line 202:
* Psoriasiform [[hyperplasia]]
* Psoriasiform [[hyperplasia]]
* [[Neutrophils]] at the margins
* [[Neutrophils]] at the margins
| colspan="3" align="center" style="background:#F5F5F5;" |Risk factors include
| align="center" style="background:#F5F5F5;" |Risk factors include
* [[Stress]]
* [[Stress]]


Line 202: Line 208:
* [[Superinfection]] with bacteria and [[candida]]
* [[Superinfection]] with bacteria and [[candida]]
Generalized seborrheic [[erythroderma]] in immunodeficient patients
Generalized seborrheic [[erythroderma]] in immunodeficient patients
|
|
|-
|-
![[Melanoma|Malignant melanoma]]
![[Melanoma|Malignant melanoma]]
!
!
!
!
!
Line 220: Line 229:
|-
|-
![[Bowen’s disease]]
![[Bowen’s disease]]
!
!
!
!
!
Line 236: Line 246:
|-
|-
![[Basal cell carcinoma|Superficial basal cell carcinoma]]
![[Basal cell carcinoma|Superficial basal cell carcinoma]]
!
!
!
!
!
Line 252: Line 263:
|-
|-
![[Basal cell carcinoma|Pagetoid basal cell carcinoma]]
![[Basal cell carcinoma|Pagetoid basal cell carcinoma]]
!
!
!
!
!
Line 268: Line 280:
|-
|-
![[Intraductal papilloma|Benign intraductal papilloma]]
![[Intraductal papilloma|Benign intraductal papilloma]]
!
!
!
!
!
Line 284: Line 297:
|-
|-
!Pagetoid dyskeratosis
!Pagetoid dyskeratosis
!
!
!
!
!
Line 304: Line 318:
* Common among [[perimenopausal]]<nowiki/>women
* Common among [[perimenopausal]]<nowiki/>women
* Usually resolve spontaneously
* Usually resolve spontaneously
!
!
!
!
!
Line 318: Line 333:
|-
|-
!Nipple duct adenoma
!Nipple duct adenoma
!
!
!
!
!
Line 334: Line 350:
|-
|-
!Benign Toker cell  hyperplasia
!Benign Toker cell  hyperplasia
!
!
!
!
!
Line 359: Line 376:
!
!
!+
!+
!
!
!
!
!
Line 366: Line 384:
|-
|-
![[Mondors disease]]
![[Mondors disease]]
!
!
!
!
!
Line 382: Line 401:
|-
|-
![[Breast abscess]]
![[Breast abscess]]
!Benign
!
!
* [[Benign]]
* No increased risk of [[malignancy]]
!
!
!
!
Line 391: Line 411:
!
!
!+
!+
!
!
* [[Breast]][[tenderness]]
* Swollen [[breast]][[tissue]]
!
!
!
!
!
!
[[Breast]] [[parenchyma]][[inflammation]]:
* [[Acute]] [[mastitis]]: [[Staphylococcus]] [[infection]]
* [[Granulomatous]] [[mastitis]]: [[Tuberculosis]] or [[sarcoidosis]][[infection]]
!
!
|
|-
|-



Revision as of 22:04, 20 February 2019

Paget's disease of the breast Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Paget's disease of the breast from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Biopsy

Ultrasonography

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Paget's disease of the breast differential diagnosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Paget's disease of the breast differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Paget's disease of the breast differential diagnosis

CDC on Paget's disease of the breast differential diagnosis

Paget's disease of the breast differential diagnosis in the news

Blogs on Paget's disease of the breast differential diagnosis

Directions to Hospitals Treating Paget's disease of the breast

Risk calculators and risk factors for Paget's disease of the breast differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]

Overview

Paget's disease of the breast must be differentiated from atopic dermatitis, eczema, psoriasis, malignant melanoma, Bowen's disease, basal cell carcinoma, and pagetoid dyskeratosis.[1][2]

Differential Diagnosis

Paget’s disease of the breast must be differentiated from other benign and malignant processes of nipple-areola complex such as:[1][2]

Category Diseases Benign or Malignant Etiology Clinical manifestations Para-clinical findings Gold Standard Associated factors
Symptoms Physical examination
Lab Findings Histopathology
Appearance Itching Mastalgia Breast Exam Other Serum IgE
Single/

Multiple

Rash Involved areas Nipple

DIscharge

Erythema
Skin disorders Atopic dermatitis Benign
  • Epidermal barrier dysfunction
  • Immune dysregulation
Multiple
  • Young children -Scalp, cheeks amd extensor surface
  • Adolescents -flexural areas and buttock-thigh creases
  • Adults - facial involvement and skin flexures
+
  • Infra-auricular and retro-auricular fissuring
  • Nipple eczema
  • White dermographism
  • Perifollicular accentuation
  • Epidermal psoriasiform hyperplasia
  • Marked intercellular edema with spongiotic vesiculation
Allergic contact dermatitis[3] Benign May be multiple after 1-2 days of exposure Erythematous well-demarcated papules Surrounding the area in contact with the offending agent + + Nl
Irritant contact dermatitis[4] Benign Usually single immediately after the exposure Well-demarcated red patch with a glazed surface Any area in contact with the irritant + + Nl
  • Cumulative exposure to irritants
  • Negative hypersensitivity tests
Psoriasis Benign Multiple Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales
  • Scalp
  • Trunk
  • Gluteal cleft
  • Extensor surface of elbows and knees
+ + + Nl Risk factors include
Chronic eczema Benign
Scalp, face, trunk, postauricular, diaper area and axilla + +
Nl Risk factors include

Generalized seborrheic erythroderma in immunodeficient patients

Malignant melanoma
Bowen’s disease
Superficial basal cell carcinoma
Pagetoid basal cell carcinoma
Benign intraductal papilloma
Pagetoid dyskeratosis
Lactiferous duct ectasia Benign
Nipple duct adenoma
Benign Toker cell hyperplasia
Mastitis Benign +
Mondors disease
Breast abscess + ±

Breast parenchymainflammation:

References

  1. 1.0 1.1 Gaspari, Eleonora; Ricci, Aurora; Liberto, Valeria; Scarano, Angela Lia; Fornari, Maria; Simonetti, Giovanni (2013). "An Unusual Case of Mammary Paget's Disease Diagnosed Using Dynamic Contrast-Enhanced MRI". Case Reports in Radiology. 2013: 1–5. doi:10.1155/2013/206235. ISSN 2090-6862.
  2. 2.0 2.1 Lopes Filho, Lauro Lourival; Lopes, Ione Maria Ribeiro Soares; Lopes, Lauro Rodolpho Soares; Enokihara, Milvia M. S. S.; Michalany, Alexandre Osores; Matsunaga, Nobuo (2015). "Mammary and extramammary Paget's disease". Anais Brasileiros de Dermatologia. 90 (2): 225–231. doi:10.1590/abd1806-4841.20153189. ISSN 1806-4841.
  3. Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009). "Allergic and irritant contact dermatitis". Eur J Dermatol. 19 (4): 325–32. doi:10.1684/ejd.2009.0686. PMID 19447733.
  4. Bains SN, Nash P, Fonacier L (October 2018). "Irritant Contact Dermatitis". Clin Rev Allergy Immunol. doi:10.1007/s12016-018-8713-0. PMID 30293200.